Monopar Therapeutics - 53 Year Dividend History | MNPR

Historical dividend payout and yield for Monopar Therapeutics (MNPR) since 1971. The current TTM dividend payout for Monopar Therapeutics (MNPR) as of May 20, 2024 is $0.00. The current dividend yield for Monopar Therapeutics as of May 20, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.011B $0.000B
Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.
Stock Name Country Market Cap PE Ratio